These reports suggest that FOXA1 may function as a tumor suppressor in HCC, and their results are consistent with our finding that the expression of FOXA1 was suppressed in liver cancer cells with activated Wnt signaling. The gene discussed is FOXA1; the disease is hepatocellular carcinoma.